In a world where traditional drug discovery can take over a decade with a success rate hovering in the single digits, RNA-based therapeutics are emerging as a revolutionary force. With the integration of artificial intelligence, this field is not just advancing; it's experiencing a quantum leap. To
For individuals with compromised immune systems, such as those recovering from intensive cancer treatments, the common herpes simplex virus can transform from a manageable nuisance into a severe, life-threatening adversary. The clinical challenge intensifies dramatically when the virus evolves
For patients diagnosed with acute myeloid leukemia, a notoriously aggressive blood cancer, the current standard of care initially offers a powerful ray of hope, but this victory is often fleeting as the treatment almost always fails when the cancer learns to outsmart it. This life-saving therapy
For patients diagnosed with the notoriously aggressive small cell lung cancer, the initial success of treatment often conceals a brutal truth about the formidable battle that lies ahead. This particular form of lung cancer presents one of modern oncology's most persistent and heartbreaking
A profound paradox exists within modern pharmacology where the treatments designed to combat deadly diseases can simultaneously inflict severe and lasting damage on the human brain. For countless individuals undergoing treatment for conditions like HIV and cancer, this is a harsh reality; up to
A new multi-million-dollar investment is poised to reshape the landscape of cancer research by focusing intensely on the unique health challenges faced by the communities of South Texas. The Cancer Prevention Research Institute of Texas (CPRIT) has announced a significant financial commitment of
